Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
18,050,135
-
Share change
-
+666,625
-
Total reported value
-
$1,806,360,430
-
Put/Call ratio
-
35%
-
Price per share
-
$100.09
-
Number of holders
-
238
-
Value change
-
+$73,339,806
-
Number of buys
-
130
-
Number of sells
-
77
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2024
As of 30 Sep 2024,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
238 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,050,135 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Stephens Investment Management Group LLC, CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, and VILLERE ST DENIS J & CO LLC.
This page lists
239
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.